@article{Portugaliza2022,

title = {Plasmodium falciparum sexual conversion rates can be affected by artemisinin-based treatment in naturally infected malaria patients},

author = {Harvie P. Portugaliza and H. Magloire Natama and Pieter Guetens and Eduard Rovira-Vallbona and Athanase M. Som\'{e} and Aida Millogo and D. Florence Ou\'{e}draogo and Innocent Val\'{e}a and Hermann Sorgho and Halidou Tinto and Nguyen Hong and Antonio Sitoe and Rosauro Varo and Quique Bassat and Alfred Cort\'{e}s and Anna Rosanas-Urgell},

url = {https://linkinghub.elsevier.com/retrieve/pii/S2352396422003802},

doi = {10.1016/j.ebiom.2022.104198},

issn = {23523964},

year  = {2022},

date = {2022-01-01},

journal = {eBioMedicine},

volume = {83},

pages = {104198},

abstract = {BACKGROUND Artemisinins (ART) are the key component of the frontline antimalarial treatment, but their impact on Plasmodium falciparum sexual conversion rates in natural malaria infections remains unknown. This is an important knowledge gap because sexual conversion rates determine the relative parasite investment between maintaining infection in the same human host and transmission to mosquitoes. METHODS The primary outcome of this study was to assess the impact of ART-based treatment on sexual conversion rates by comparing the relative transcript levels of pfap2-g and other sexual ring biomarkers (SRBs) before and after treatment. We analysed samples from previously existing cohorts in Vietnam, Burkina Faso and Mozambique (in total},

keywords = {Artemisinin, Malaria transmission, pfap2-g, Plasmodium falciparum, Sexual conversion},

pubstate = {published},

tppubtype = {article}

}